41 results on '"Kloft C"'
Search Results
2. High-Dosage Fosfomycin Results in Adequate Plasma and Target-Site Exposure in Morbidly Obese and Nonobese Nonhyperfiltration Patients
3. 112P Prognostic impact of five serum biomarkers in patients with advanced non-small cell lung cancer (NSCLC): An exploratory analysis
4. Extrapolation bayésienne de la préclinique à la clinique
5. 575P TLD-1, a novel liposomal doxorubicin, in patients (pts) with advanced solid tumours: Dose escalation part of a multicenter open-label phase I trial (SAKK 65/16)
6. Risk of target non-attainment in obese compared to non-obese patients in calculated linezolid therapy
7. P072 Evaluation of dosing strategies of anti-TNFα monoclonal antibodies using pharmacokinetic modelling and simulation
8. Patient-tailored tamoxifen dosing based on an increased quantitative understanding of its complex pharmacokinetics: A novel integrative modelling approach
9. Measurement of soft tissue drug concentrations in morbidly obese and non-obese patients – A prospective, parallel group, open-labeled, controlled, phase IV, single center clinical trial
10. P93 Semi-mechanistic modelling of hydrocortisone pharmacokinetics in paediatric patients with adrenal insufficiency
11. Elimination of Doripenem during Dialysis and Pharmacokinetic Evaluation of Posthemodialysis Dosing for Patients Undergoing Intermittent Renal Replacement Therapy
12. Pharmacokinetics of Cefuroxime in Synovial Fluid
13. Penetration of linezolid into synovial fluid and muscle tissue after elective arthroscopy
14. Translational Pharmacometric Evaluation of Typical Antibiotic Broad-Spectrum Combination Therapies AgainstStaphylococcus AureusExploitingIn VitroInformation
15. P485 Dosing infliximab in Crohn's disease: Is adjustment for body size justified?
16. Open-label, randomized study of individualized, pharmacokinetically (PK)-guided dosing of paclitaxel combined with carboplatin or cisplatin in patients with advanced non-small-cell lung cancer (NSCLC)
17. 3066 Pharmacokinetically (PK)-guided dosing of paclitaxel in combination with carboplatin in advanced non-small cell lung cancer (NSCLC) is gender dependent: Updated results of the randomized CEPAC-TDM study
18. Pharmacometrics Markup Language (PharmML): Opening New Perspectives for Model Exchange in Drug Development
19. Pharmakokinetik und Pharmakodynamik der Antibiotikatherapie
20. A Review of Mixed-Effects Models of Tumor Growth and Effects of Anticancer Drug Treatment Used in Population Analysis
21. DOP061 Pharmacokinetic considerations for optimising dosing regimens of infliximab in patients with Crohn's disease
22. Quantifying the impact of nevirapine-based prophylaxis strategies to prevent mother-to-child transmission of HIV-1 using the population approach
23. White Paper: Landscape on Technical and Conceptual Requirements and Competence Framework in Drug/Disease Modeling and Simulation
24. Population pharmacokinetics and pharmacodynamic evaluation of intravenous and enteral moxifloxacin in surgical intensive care unit patients
25. Quantifying the Impact of Nevirapine-Based Prophylaxis Strategies To Prevent Mother-to-Child Transmission of HIV-1: a Combined Pharmacokinetic, Pharmacodynamic, and Viral Dynamic Analysis To Predict Clinical Outcomes
26. 124 INVITED Considerations in PK-PD of Antibodies
27. Microdialysis feasibility investigations with the non-hydrophilic antifungal voriconazole for potential applications in nonclinical and clinical settings
28. In vitro pharmacodynamic models to determine the effect of antibacterial drugs
29. Population pharmacokinetic modelling and simulation of single and multiple dose administration of meloxicam in cats
30. Grundlagen rationaler Pharmakotherapie bei Intensivpatienten – Blickpunkt Antimykotika
31. Persistence of nevirapine in breast milk and plasma of mothers and their children after single-dose administration
32. Population pharmacokinetic data analysis of three phase I studies of matuzumab, a humanised anti-EGFR monoclonal antibody in clinical cancer development
33. Contribution of the active metabolite M1 to the pharmacological activity of tesofensine in vivo : a pharmacokinetic-pharmacodynamic modelling approach
34. Effect of severity of sepsis on tissue concentrations of linezolid
35. PMH51 ADHERENCE OF ALZHEIMER PATIENTS TO ANTIDEMENTIA DRUGS
36. In Vivo Efficacy and Pharmacokinetics of Voriconazole in an Animal Model of Dermatophytosis
37. Does Linezolid Inhibit Its Own Metabolism?—Population Pharmacokinetics As a Tool to Explain the Observed Nonlinearity in Both Healthy Volunteers and Septic Patients
38. Population Pharmacokinetics of Sibrotuzumab, A Novel Therapeutic Monoclonal Antibody, in Cancer Patients
39. Cerebrospinal fluid pharmacokinetics after different dosage regimens of intraventricular etoposide
40. Development of a liquid chromatography method for the determination of linezolid and its application to in vitro and human microdialysis samples
41. Individualised dosing strategy for high-dose carboplatin in patients with germ cell cancer
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.